Genus I. Escherichia Castellani and Chalmers 1919, 941TAL

Total Page:16

File Type:pdf, Size:1020Kb

Genus I. Escherichia Castellani and Chalmers 1919, 941TAL FAMILY I. ENTEROBACTERIACEAE 607 kazakii in most biochemical reactions, including production of a by Kosako et al. (1996) indicated that Enterobacter kobei is the yellow pigment. However, they were only 43% related to E. sa- closest relative of Enteric Group 69. kazakii by DNA–DNA hybridization. Recent DNA relatedness data Genus I. Escherichia Castellani and Chalmers 1919, 941TAL FLEMMING SCHEUTZ AND NANCY A. STROCKBINE Esch.er.iЈchi.a. M.L. fem. n. Escherichia named after Theodor Escherich, who isolated the type species of the genus. -lm, occurring singly cannot be used by E. coli and E. vulneris, whereas a smaller pro 6.0–2.0 ן Straight cylindrical rods, 1.1–1.5 or in pairs. Conform to the general definition of the family En- portion of E. fergusonii and E. hermannii exhibit immediate or terobacteriaceae. Gram negative. Motile by peritrichous flagella or delayed use of this substrate. Growth on Simmons’ citrate agar nonmotile. Aerobic and facultatively anaerobic having both a by E. blattae is variable and probably strain specific. respiratory and a fermentative type of metabolism, but anaero- Lysine is decarboxylated by the majority of strains. Exceptions genic biotypes occur. Oxidase negative. Chemoorganotrophic. include “metabolically inactive” E. coli strains, the majority of Both acid and gas are formed from most fermentable carbo- enteroinvasive E. coli strains (EIEC), and E. hermannii. Ornithine hydrates, but i-inositol is not utilized and d-adonitol is utilized is decarboxylated by all species except by E. vulneris and a little only by Escherichia fergusonii. Lactose is fermented by most strains less than half of E. coli strains. Indole is produced by all species of Escherichia coli, but fermentation may be delayed or absent except E. blattae and E. vulneris. in Escherichia blattae, Escherichia hermannii, Escherichia fergusonii, Other tests that help in differentiating between the species and Escherichia vulneris. Do not grow in KCN (with the exception of Escherichia include growth in potassium cyanide, malonate util- of E. hermannii and a small proportion of E. vulneris). Usually ization, and acid production from d-adonitol, d-arabitol, cello- do not produce H2S. E. coli occur naturally in the lower part of biose, dulcitol, lactose, d-mannitol, melibiose, d-sorbitol, and mu- the intestine of warm-blooded animals, E. blattae in the hind-gut cate. See Table BXII.c.197. of cockroaches, and E. fergusonii, E. hermannii, and E. vulneris are Molecular data Findings from the comparison of 16S rDNA found in the intestine, as well as extraintestinal sites of warm- sequences performed with strains of E. coli, Salmonella spp., and blooded animals. Seven copies of the rrn operon with genes C. freundii have shown a close phylogenetic relatedness between coding for 16S, 23S, and 5S rRNA are present on the chromo- these bacteria (Ahmad et al., 1990; Cilia et al., 1996; Chang et some of E. coli. Comparative sequence analysis between the genes al., 1997). Analysis of 16S rDNA sequences separates the two for 16S rRNA of E. coli, E. vulneris, and E. hermannii and ho- Salmonella species (S. enterica and S. bongori) from the complex mologous genes from all eubacteria places E. coli and E. vulneris of E. coli and Shigella, and shows that E. hermannii is more closely together in a tightly related cluster with shigellae, and E. her- related to Salmonella enterica and C. freundii (Christensen et al., mannii between Salmonella spp. and Citrobacter freundii (Cilia et 1998). This analysis is unable to separate inter-operon variation al., 1996). Based on 16S rRNA sequencing, escherichiae belong of E. coli from strains of E. coli and from Shigella. Patterns of in the Gammaproteobacteria. sequence heterogeneity in strains from the E. coli Collection of C of the DNA is: 48–59. Reference (ECOR) (Ochman and Selander, 1984) have been ם The mol% G Type species: Escherichia coli (Migula 1895) Castellani and located at regions V1 and V6 of cloned 16S rRNA genes (Mar- Chalmers 1919, 941 (Bacillus coli Migula 1895, 27.) tinez-Murcia et al., 1999). Average DNA relatedness assessed by DNA–DNA hybridization FURTHER DESCRIPTIVE INFORMATION among Escherichia species ranges from 29% to 94% (Table Cell morphology Escherichiae are straight, cylindrical, BXII.c.198). DNAs from different strains of E. coli are closely Gram-negative rods with rounded ends that are 1.1–1.5 lm in related (average, 84%; Table BXII.c.198). With the exception of diameter and 2.0–6.0 lm in length. They occur singly or in pairs S. boydii serotype 13, the DNAs of E. coli and the four Shigella and can be motile by peritrichous flagella or nonmotile. Fig. species show such a high degree of relatedness (average 80–87%, BXII.c.191 shows negatively stained preparations of each of the except S. boydii type 13, which is about 65%) that these species Escherichia species. See Nanninga (1985) for a comprehensive should be considered as a single species (Brenner et al., 1973a). treatment of the ultrastructure of E. coli. The distinction between these bacteria prevails, however, for rea- sons of historical/medical precedent and to avoid confusion in Phylogenetic and systematic treatment The genus consists of the literature and with existing surveillance systems. five species: E. coli, E. hermannii, E. fergusonii, E. vulneris, and E. Based on complete sequencing of the K-12 strain MG1655 blattae. Biochemical reactions that will help in differentiating be- (Blattner et al., 1997), it is estimated that the E. coli lineage tween the species of Escherichia are listed in Table BXII.c.197. diverged from the Salmonella lineage some 100 million years ago Biochemical reactions Escherichiae produce strong acids and (Lawrence and Ochman, 1998). This is a little less than the 120– usually gas from the fermentation of d-glucose (positive in the 160 million years estimated by calibration of the rate of 16S rRNA Methyl Red test) and do not produce acetyl-methyl carbinol (ace- evolution in bacteria (Ochman and Wilson, 1987). The chro- toin) (negative in the Voges–Proskauer test). Sodium acetate is mosome of E. coli strain MG1655 is 4,639,221 bp and contains frequently used as a sole carbon source, except by E. blattae and 4,288 open reading frames (ORFs). Approximately 18% of these a majority of E. vulneris strains. Citrate (Simmons’ citrate agar) ORFs represent genes that have been acquired and have persisted 608 FAMILY I. ENTEROBACTERIACEAE A B C D E FIGURE BXII.c.191. Electron micrographs of E. blattae strain 2928-78 (A), E. coli O157:H7 strain EDL933 (B), E. fergusonii strain 2460-89 (C), E. .nm 1000 ס hermannii strain 2456-88 (D), and E. vulneris strain 2485-88 (E) prepared by negatively staining in 0.5% (w/v) uranyl acetate. Bar (Micrograph courtesy of Charles D. Humphrey, CDC.) since divergence. This is similar to estimates based on analysis serotype O157:H7, the genome of which is 5.5 Mb in size, 859 of codon usage, indicating that 16% of sequenced genes arose Kb larger than that of the laboratory strain K-12 (Hayashi et al., through horizontal transfer (Me´digue et al., 1991). The ability 2001; Perna et al., 2001). The genome sizes of 14 E. coli strains of individual strains and lineages to acquire foreign DNA results from the five major subgroups in the ECOR (Ochman and Se- in great heterogeneity in both individual genes and in the size lander, 1984) range from 4.66–5.30 Mb (Bergthorsson and Och- of the E. coli chromosome. This is exemplified by the unusual man, 1995), and the uropathogenic E. coli strain J96 genome is GENUS I. ESCHERICHIA 609 TABLE BXII.c.197. Differentiation of the five species of Escherichiaa,b Test E. coli E. coli (metabolically inactive strains) E. blattae E. fergusonii E. hermannii E. vulneris מ ם ם מ [ם] ם Indole מ cמ [מ] d מ מ Citrate, Simmons [ם] dמ ם ם d ם Lysine decarboxylase מ ם ם ם [מ] Ornithine decarboxylase d ם ם ם eמ מ ם Motility [מ] ם מ מ מ מ KCN, growth [ם] מ d ם מ מ Malonate utilization ם ם ם ם מ ם D-Glucose, gas Acid production from: מ מ ם מ מ מ d-Adonitol מ מ ם מ מ מ d-Arabitol ם ם ם מ מ מ Cellobiose מ [מ] d מ Dulcitol d d f[מ] f dמ מ [מ] ם Lactose ם ם ם מ ם ם d-Mannitol ם מ מ מ d [ם] Melibiose מ מ מ מ d ם d-Sorbitol [ם] ם מ d d ם Mucate d [ם] ם מ d ם Acetate utilization d ם מ מ מ מ Yellow pigmentation aData compiled from references Farmer (1999), Cowan et al. (1995), Holt et al. (1994), and Richard (1989). Reactions for indole for E. fergusonii and melibiose for E. coli differ slightly in these references. The reactions listed in this table are supported by our own unpublished data. .1ЊC ע positive. Results are for 48 h incubation at 36Њ 100%–90 ,ם ;positive 89%–76 ,[ם] ;positive; d, 26–75% positive 25%–11 ,[מ] ;positive 10%–0 ,מ :bSymbols cDelayed positive in approximately a fifth of E. hermannii strains. dDelayed positive in a third of E. hermannii strains. e75% of E. blattae strains will become motile after incubation of more than 2 d. fDelayed positive in approximately two thirds of E. fergusonii and E. vulneris strains. TABLE BXII.c.198. DNA relatedness among escherichiaea Labeled Average percent relatedness DNA from E. coli E. blattae E. fergusonii E. hermannii E. vulneris E. coli 84 42 64 38 43 E. blattae 90 39 29 E. fergusonii 57 94 59 E.
Recommended publications
  • Current Topics in Microbiology and Immunology
    Current Topics in Microbiology and Immunology Volume 431 Series Editors Rafi Ahmed School of Medicine, Rollins Research Center, Emory University, Atlanta, GA, USA Shizuo Akira Immunology Frontier Research Center, Osaka University, Suita, Osaka, Japan Klaus Aktories Faculty of Medicine, Institute of Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Freiburg, Baden-Württemberg, Germany Arturo Casadevall W. Harry Feinstone Department of Molecular Microbiology & Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA Richard W. Compans Department of Microbiology and Immunology, Emory University, Atlanta, GA, USA Jorge E. Galan Boyer Ctr. for Molecular Medicine, School of Medicine, Yale University, New Haven, CT, USA Adolfo Garcia-Sastre Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA Bernard Malissen Parc Scientifique de Luminy, Centre d‘Immunologie de Marseille-Luminy, Marseille, France Rino Rappuoli GSK Vaccines, Siena, Italy The review series Current Topics in Microbiology and Immunology provides a synthesis of the latest research findings in the areas of molecular immunology, bacteriology and virology. Each timely volume contains a wealth of information on the featured subject. This review series is designed to provide access to up-to-date, often previously unpublished information. 2019 Impact Factor: 3.095., 5-Year Impact Factor: 3.895 2019 Eigenfaktor Score: 0.00081, Article Influence Score: 1.363 2019 Cite Score: 6.0, SNIP: 1.023, h5-Index: 43 More
    [Show full text]
  • Escherichia Vulneris As a Cause of Bacteremia in a Patient with Chronic
    110 Correspondence 3. Auerbach O. Acute generalized miliary tuberculosis. Am J Pathol 12. Takhtani D, Gupta S, Suman K, Kakkar N, Challa S, Wig JD, et al. 1944;20:121—36. Radiology of pancreatic tuberculosis: a report of three cases. Am 4. Bhansali SK. Abdominal tuberculosis. Experience with 300 cases. J Gastroenterol 1996;91:1832—4. Am J Gastroenterol 1977;67:324—37. 13. Chen CH, Yang CC, Yeh YH, Yang JC, Chou DA. Pancreatic 5. Franco-Paredes C, Leonard M, Jurado R, Blumberg HM, Smith RM. tuberculosis with obstructive jaundice–—a case report. Am J Tuberculosis of the pancreas: report of two cases and review of Gastroenterol 1999;94:2534—6. the literature. Am J Med Sci 2002;323:54—8. 14. Varshney S, Johnson CD. Tuberculosis of the pancreas. Postgrad 6. Pombo F, Diaz Candamio MJ, Rodriguez E, Pombo S. Pancreatic Med J 1995;71:564—6. tuberculosis: CT findings. Abdom Imaging 1998;23:394—7. 7. Demir K, Kaymakoglu S, Besisik F, Durakoglu Z, Ozdil S, Kaplan Y, Ariel S. Eyal* et al. Solitary pancreatic tuberculosis in immunocompetent V.O.L. Karusseit patients mimicking pancreatic carcinoma. J Gastroenterol Hepa- Department of Surgery, University of Pretoria, tol 2001;16:1071—4. Pretoria, South Africa 8. Liu Q, He Z, Bie P.Solitary pancreatic tuberculous abscess mimick- ing pancreatic cystadenocarcinoma: a case report. BMC Gastro- *Corresponding author. Tel.: +27 82 375 4155 enterol 2003;3:1—6. E-mail address: [email protected] 9. Rezeig MA, Fashir BM, Al-Suhaibani H, Al-Fadda M, Amin T, Eisa H.
    [Show full text]
  • Distribution of Bacterial 1,3-Galactosyltransferase Genes In
    Distribution of Bacterial α1,3-Galactosyltransferase Genes in the Human Gut Microbiome Emmanuel Montassier, Gabriel Al-Ghalith, Camille Mathé, Quentin Le Bastard, Venceslas Douillard, Abel Garnier, Rémi Guimon, Bastien Raimondeau, Yann Touchefeu, Emilie Duchalais, et al. To cite this version: Emmanuel Montassier, Gabriel Al-Ghalith, Camille Mathé, Quentin Le Bastard, Venceslas Douillard, et al.. Distribution of Bacterial α1,3-Galactosyltransferase Genes in the Human Gut Microbiome. Frontiers in Immunology, Frontiers, 2020, 10, pp.3000. 10.3389/fimmu.2019.03000. inserm-02490517 HAL Id: inserm-02490517 https://www.hal.inserm.fr/inserm-02490517 Submitted on 25 Feb 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. ORIGINAL RESEARCH published: 13 January 2020 doi: 10.3389/fimmu.2019.03000 Distribution of Bacterial α1,3-Galactosyltransferase Genes in the Human Gut Microbiome Emmanuel Montassier 1,2,3, Gabriel A. Al-Ghalith 4, Camille Mathé 5,6, Quentin Le Bastard 1,3, Venceslas Douillard 5,6,7, Abel Garnier 5,6,7, Rémi Guimon 5,6,7, Bastien Raimondeau 5,6, Yann Touchefeu 8,9, Emilie Duchalais 8,9, Nicolas Vince 5,6, Sophie Limou 5,6, Pierre-Antoine Gourraud 5,6,7, David A.
    [Show full text]
  • Escherichia Fergusonii: a New Emerging Bacterial Disease of Farmed Nile Tilapia (Oreochromis Niloticus)
    Global Veterinaria 14 (2): 268-273, 2015 ISSN 1992-6197 © IDOSI Publications, 2015 DOI: 10.5829/idosi.gv.2015.14.02.9379 Escherichia fergusonii: A New Emerging Bacterial Disease of Farmed Nile Tilapia (Oreochromis niloticus) A.Y. Gaafar, A.M. Younes, A.M. Kenawy, W.S. Soliman and Laila A. Mohamed Department of Hydrobiology, National Research Centre (NRC), El-Bohooth Street (Formerly El-Tahrir St.) Dokki, Gizza 12622, Egypt Abstract: Tilapia is one of the most important cultured freshwater fish in Egypt. In June (2013) an unidentified bacterial disease outbreak occurred in earthen ponds raised Nile tilapia (Oreochromis niloticus). The API 20E test identified the strain as sorbitol-negative and positive for ADH, ornithine decarboxylase and amygdalin and provided the code 5144113, corresponding to E. fergusonii. The clinical signs of diseased fish showed emaciation, focal reddening of the skin at the base of the fins, exophthalmia with inflammation of periorbital area. Postmortem lesions showed enlargement of gallbladder and spleen with discolored hepatopancreas and congested posterior kidney. Lethal Dose fifty (LD50 ) was performed for experimental infection studies. Histopathological examination of naturally as well as experimentally infected specimens revealed pathological lesions in the hepatopancreas, posterior kidney, spleen, myocardium, skin and gills. The lesions ranged from circulatory, degenerative changes and mononuclear cells infiltrations to necrotic changes in the corresponding organs. As a conclusion, this study was the first evidence that E. fergusonii can infect fish especially farmed tilapia, causing considerable mortality and morbidity, in heavily manured earthen ponds. E. fergusonii causes significant pathological lesions in tilapia that are comparable to other susceptible terrestrial animals.
    [Show full text]
  • Systemic Infection Induced by Campylobacter Jejuni: Development of a Mouse Model and Elucidation of Molecular Mechanisms Samantha Terhorst Iowa State University
    Iowa State University Capstones, Theses and Graduate Theses and Dissertations Dissertations 2012 Systemic infection induced by Campylobacter jejuni: Development of a mouse model and elucidation of molecular mechanisms Samantha Terhorst Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/etd Part of the Microbiology Commons Recommended Citation Terhorst, Samantha, "Systemic infection induced by Campylobacter jejuni: Development of a mouse model and elucidation of molecular mechanisms" (2012). Graduate Theses and Dissertations. 12653. https://lib.dr.iastate.edu/etd/12653 This Thesis is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. Systemic infection induced by Campylobacter jejuni: Development of a mouse model and elucidation of molecular mechanisms by Samantha Ashley Terhorst A thesis submitted to the graduate faculty in partial fulfillment of the requirements for the degree of MASTER OF SCIENCE Major: Toxicology Program of Study Committee: Qijing Zhang, Major Professor Byron Brehm-Stecher Paul Plummer Orhan Sahin Iowa State University Ames, Iowa 2012 Copyright © Samantha Ashley Terhorst, 2012. All rights reserved. ii TABLE OF CONTENTS ABSTRACT .....................................................................................................................
    [Show full text]
  • A Brief History of the Family of Sonja Escherich-Eisenmenger-Weber
    A Brief History of the family of Sonja Escherich-Eisenmenger-Weber © Copyright 1990 Ernst Weber, Tryon, North Carolina Part I Pfaundlers, Oetz and Piburg Part II Theodor Eseherich and Child Care in Vienna Part III Sonya Escherich-Eisenmenger, 1895 until 1936 Privately Printed By M.A. DESIGNS Tryon, NC An Introduction to Sonya & Ernst Weber An address by James M. Flack (son-in-law of Sonya Weber) at the Cosmos Club in Washington, D.C. Tuesday, October 14, 1975 on the occasion of the establishment of the Sonya & Ernst Weber Scholarship Fund. Dr. Bugliarello, Friends, Associates and Family of Sonya and Ernst Weber. It is my honor and privilege to speak on behalf of the dose members of the Weber family. Dr. Bugliarello, we are grateful to you and to Polytechnic for establishing the Sonya and Ernst Weber Scholarship Fund. The criterion for the awards - based on excellence and regardless of need is most appropriate. This is consonant with the lives of the Webers. They have searched for the good - for things of real value. And when things of value were discovered, they were able to recognize, cherish, nurture and reward them to assure their continuity and growth. Sonya and Ernst Weber are well known - both nationally and internationally, each in her and his own field. They have each been showered with honors for their achievements and contributions to a better way of life in our time and for the future to come - Ernst in the field of science as a physicist, engineer, educator and administrator; Sonya also in the field of science as a doctor of physical medicine and physical fitness.
    [Show full text]
  • Symposium Abstracts
    Symposium Abstracts S1 Microbiological Environmental Testing and Validation: Leading-edge Issues for Low-moisture Foods JEAN-LOUIS CORDIER, Nestlé Nutrition, Operations/Quality Management, Vevey, Switzerland DONALD L. ZINK, Food and Drug Administration, Center for Food Safety and Applied Nutrition, College Park, MD, USA STEVEN J. GOODFELLOW, Deibel Laboratories, Inc., Gainesville, FL, USA MARK A. MOORMAN, Kellogg Company, Battle Creek, MI, USA ROBERT L. BUCHANAN, University of Maryland, Center for Food Safety and Security Systems, College Park, MD, USA Recent outbreaks of foodborne illness in several low-moisture foods (i.e., peanuts, peanut butter, cookie dough, etc.) have brought a growing public awareness of the complexities involved with the processing of this category of foods where traditional sanitation practices Symposium may not be applied or practical. As a result, the food industry and FDA have rallied to bring together best available thinking and practices necessary to assure control over foodborne hazards in such processes. However, one leading edge area that still remains a subject that offers opportunities for improvement is how control measures are verified in these processing environments through microbiological testing.This symposium will “zero in” on the challenges that face both food processors and food regulators in the area of environmental monitoring for these low moisture continuous processes. S2 Data Deluge, Interacting Players and Complex Networks in Food Sciences – Computational Tools to Tackle Food- related Complexities RéKA ALBERT, Pennsylvania State University, University Park, PA, USA MARK TAMPLIN, Food Safety Centre, Hobart, TAS, Australia GARY BARKER, Institute of Food Research, Norwich, United Kingdom JÓZSEF BARANYI, Institute of Food Research, Norwich, United Kingdom Food Science is one of the most multi-disciplinary sciences, consequently a holistic approach is not only desirable but rather a necessity, in order to integrate various food-related complex systems.
    [Show full text]
  • Issue 2, September 2011
    Quarterly Newsletter of the Belgian Society for Microbiology Issue no. 2, September 2011 Contents Welcome by the president of BSM Page 1 As indicated in the program, the morning session Membership Page 2 consists of 4 plenary lectures, while in the News from FEMS Page 2 afternoon 2 parallel sessions (bacteriology, BSM Symposium 2011 Page 3 virology) are programmed with time reserved for Theodor Escherich Page 5 short oral communications from selected Report on MRM Symposium Page 7 abstracts. PhD Corner Page 9 Call for contributions Page 10 Besides this, there will be also ample time to Composition of the BSM board Page 10 discuss during the posters session. As such this meeting is also meant as an opportunity to meet microbiology colleagues and to exchange ideas. More details of the symposium, and how to Welcome register, you will find on p 3. Concomitantly with the start of the new academic year, we send you Issue 2 of the E-Newsletter of the We also started with a series of short overviews Belgian Society for Microbiology. Since the first E- on historical data in microbiology (see p 4), and Newsletter, the BSM board was further active in continue with the PhD corner, and report on FEMS several respects. sponsored activities. The BSM Board has further worked on finalizing the BSM was also for the first time host of the FEMS th program of the symposium (Brussels, 16th November Council meeting held in Leuven 16-17 2011), the yearly most important activity of BSM. September, which was attended by 37 delegates (22 different nationalities) representing different This year’s topic is “Live, death and survival of Micro- microbiological societies unified under the organisms” emphasizing that thanks to the umbrella of FEMS, which altogether represent continuous progress in microbiological sciences, more than 30000 European microbiologists (see strategies used by micro-organisms to live and http://www.fems-microbiology.org).
    [Show full text]
  • 5Th Theodor Escherich & 2Nd AMICI Joint Symposium
    5th Theodor Escherich & 2nd AMICI Joint Symposium 8th - 9th November 2018 Neuer Med Campus, Neue Stiftingtalstraße 2 Medical University of Graz, Austria ABSTRACT BOOK If you do’t like iroes, you’re o the rog plaet (Stewart Brand, adapted) In behalf of the organizing committee of the 5th Theodor Escherich & 2nd AMICI Joint Symposium 2018 we cordially welcome you at the Medical University of Graz. We are very pleased with the high number of renowned national and international scientists oerig the topis iroioe ad aer, iroioe ad utritio, iroioe ad eiroet, egleted eers of the hua iroioe, iroiota odulatio ad the plat iroioe that hae aepted our iitatio to speak. We will have more than 200 guests from Austria and Europe, interested interdisciplinary microbiome research. The new Campus at the Medical University in Graz provides an excellent venue for this event, and we are convinced that the wonderful atmosphere in this building will support personal exchange and discussion amongst young researchers and PIs. We are particularly thankful for the fruitful interaction with the Austrian Microbiome Initiative AMICI, serving as an excellent networking platform for microbiome research – resulting in this joint adventure this year! We are extremely grateful for the generous support from our sponsors and industry partners. We are looking forward to a very fruitful meeting, The local organizing committee Gabriele Berg Gregor Christoph Robert Krause, Christine Moissl- TU Graz Gorkiewicz, MUG Högenauer, MUG MUG Eichinger, MUG www.medunigraz.at/microbiome Sehr geehrte Damen und Herren, liebe Kolleginnen und Kollegen! Bakterien, Viren, Archaen, Parasiten und Pilze – unseren Körper teilen wir mit Billionen Bakterien, die Mundhöhle, Haut und Darm besiedeln.
    [Show full text]
  • Escherichia Hermannii Infections in Humans: a Systematic Review
    Tropical Medicine and Infectious Disease Review Escherichia hermannii Infections in Humans: A Systematic Review Petros Ioannou Department of Internal Medicine & Infectious Diseases, University Hospital of Heraklion, Heraklion, Crete PC 71500, Greece; [email protected]; Tel.: +30-2810-392728, Fax: +30-2810-392359 Received: 7 January 2019; Accepted: 18 January 2019; Published: 21 January 2019 Abstract: Eshcerichia hermannii is a member of the Enterobacteriaceae, first described in 1982 and reclassified as a distinct species in the Escherichia genus after identifying biochemical and genomic differences from E. coli. It is a rare cause of human infections and is supposed to be a co-infector rather than an autonomous cause of infection. The aim of this systematic review was to record and evaluate all available evidence regarding human infections by E. hermannii. A systematic review of PubMed (through 21 December 2018) for studies providing epidemiological, clinical, and microbiological information, as well as treatment data and outcomes of E. hermannii infections was performed. A total of 16 studies, containing data of 17 patients, were eventually included in the analysis. The most common E. hermannii infections were bacteremias, urinary tract, and central nervous system infections. The complication rate, like the occurrence of sepsis, was high. Cephalosporins and aminoglycosides were the most common agents used for treatment. This systematic review describes bacterial infections by E. hermannii and provides information on the epidemiology, clinical presentation, antibiotic resistance, treatment, and outcomes associated with these infections. Keywords: Escherichia hermannii; bacteremia; UTI; urinary tract infection 1. Introduction Escherichia hermannii is a gram-negative bacterium that belongs in the family of Enterobacteriaceae and was first described in 1982 [1].
    [Show full text]
  • Escherichia Coli Patógeno Extra Intestinal (Expec): Atributos De Virulencia, Epidemiología Molecular Y Resistencia a Antibióticos
    Escherichia coli patógeno extra intestinal (ExPEC): Atributos de virulencia, Epidemiología Molecular y Resistencia a Antibióticos Tesis de Doctorado PEDECIBA Área Biología, Sub-área Microbiología Rafael Vignoli Orientador: Dr. Alejandro Chabalgoity Co-orientador: Dr. Gabriel Gutkind Departamento de Bacteriología y Virología Instituto de Higiene-Facultad de Medicina Montevideo-Uruguay Abreviaturas: ABC ATP binding cassette AMM Alta Más a Molecular AUC ROC Area bajo la Curva ROC BLEA β-lactamasa de Espectro Ampliado BLEE β-lactamasa de Espectro Extendido BMM Baja Más a Molecular CEACAMs Moléculas de antígeno carcinoembrionario relacionado a adhesión celular CIM Concentrción Inhibitoria Mínima CLSI Clinical and Laboratory Standards Institute CNF-1 Factor necrosante de toxicidad tipo 1 DAF Decay Accelerating Factor Dam deoxi-adenosin metiltransferasa EUCAST European Committee on Antimicrobial Susceptibility Testing ExPEC E. coli patógenas extra intestinales GCA Grupo Clonal A GF Grupos Filogenéticos GRTFQ Genes de Resistencia Transferibles a Fluoro Quinolonas GTPasa guanosina trifosfatasa IS Secuencia de Inserción ITU Infección del Tracto Urinario MATE Multidrug And Toxic-compound Extrusion MFS Major Facilitator Superfamily MLST Multi Locus Sequence Typing (Tipificación de Secuencias Multi Locus) MPS Muerte Post Segregasional MR Manosa Resistente MRD Multi Resistentes a Drogas MS Manosa Sensible NAcGlc N-acetil glucosamina NAcMur N-acetilmurámico NADPH Nicotinamida Adenin di nucleótido fosfato forma reducida PBP Penicillin Binding Proteins
    [Show full text]
  • Performance Characterization of the IRIDICA™ BAC SFT Assay* for Detection and Identification of Diverse Bacteria and Candida in Tissues and Body fluids
    Performance characterization of the IRIDICA™ BAC SFT Assay* for detection and identification of diverse bacteria and Candida in tissues and body fluids Mark W. Frinder, David Metzgar, Megan Rounds, Heather E. Carolan, Donna M. Toleno, Rangarajan Sampath, David J. Ecker, Lawrence B. Blyn Ibis Biosciences, an Abbott Company, Carlsbad, CA, USA Color Key Table 2: Potentially interfering substances tested with the 4 core organisms at 3X Objectives: Identifying causal organisms in Results: The BAC SFT Assay was able to detect and identify all IRIDICA detections, matched LOD in synovial Fluid, muscle tissue, and diluent matrices.Data shown reflects IRIDICA detections, unmatched Standard of care detections, missed by IRIDICA tissue and body fluid infections through tested organisms at concentrations of 5 to 1000 CFU/sample, concentration in the final 5ml sample. No interference was observed (all 4 targets and their associated antibiotic resistance markers were successfully culture-based methods is time-consuming and the sensitivity of the assay was comparable between Burkholderia vietnamiensis (1) and challenging. Culture-based methods are tissue, body fluid, and sample diluent matrices (Figure 1). The detected in 3/3 samples). Micrococcus luteus (1) Corynebacterium striatum (1) often rendered ineffective by antibiotic assay was able to detect organisms in the presence of diverse Test Substance Concentration Test Substance Concentration Corynebacterium accolens (2) Propionibacterium acnes (5) Pseudomonas entomophila/putida (1) pre-treatment, the presence of fastidious or tissues or fluids (Table 1), and potentially interfering Bilirubin 171 µmol/L * Doxycycline 67.5 µmol/L Acinetobacter junii (4) Hemoglobin 2 g/L Fluconazole 245 µmol/L uncultureable species, and growth inhibition substances (Table 2).
    [Show full text]